|20th November 2020||David F Burgstahler||4,936,926||Other acquisition or disposition||$0.00|
|20th November 2020||Sriram Venkataraman||4,936,926||Other acquisition or disposition||$0.00|
|20th November 2020||Capital Partners Iii Gp, L.P. Avista||4,936,926||Other acquisition or disposition||$0.00|
|1st October 2020||Brian A Markison||2,277||Grant/award etc.||$0.00|
|10th August 2020||Brian A Markison||1,354||Grant/award etc.||$0.00|
|21st May 2020||Fred G Weiss||17,778||Payment by withholding||$4.60||$81,778.80|
|21st May 2020||Gregory L Cowan||11,112||Payment by withholding||$4.60||$51,115.20|
|20th May 2020||Brian A Markison||249,787||Grant/award etc.||$0.00|
|20th May 2020||Fred G Weiss||38,716||Grant/award etc.||$0.00|
|20th May 2020||Gregory L Cowan||38,716||Grant/award etc.||$0.00|
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 7/10.
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.